- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05591196
Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke (HARNESS)
The recovery from a stroke is often incomplete. It is the leading cause of acquired permanent disability in the adult population. Persistent functional loss of the hand and arm contributes significantly to disability. However, the current standard of care to treat hand and arm movements are inadequate. There is an urgent need for innovative and effective therapies for recovery of the upper limb after stroke.
Growing evidence shows that electrical spinal cord stimulation, combined with activity-dependent rehabilitation, enables voluntary movement of paralyzed muscles in some neurologic disorders, such as spinal cord injury. The investigators hypothesize that spinal networks that lost control after stroke can be activated by non-invasive electrical stimulation of the spinal cord to improve functional recovery.
The aims of the study are:
- to determine the improvements in hand and arm function that result from the combined application of non-invasive spinal stimulation and activity-based rehabilitation. Surface electrodes placed over the skin of the neck will be used for non-invasive electrical stimulation of the spinal cord. Functional task practice will be used for activity-dependent rehabilitation,
- to evaluate long-lasting benefits to hand and arm function that persist beyond the period of spinal stimulation.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Fatma Inanici
- Phone Number: 206-787-2692
- Email: finanici@uw.edu
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98105
- Recruiting
- University of Washington
-
Contact:
- Fatma Inanici, MD, Ph.D.
- Phone Number: 206-787-2692
- Email: finanici@uw.edu
-
Sub-Investigator:
- Fatma Inanici, MD, PhD
-
Principal Investigator:
- Chet T Moritz, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Radiologically documented single ischemic stroke resulted in hemiplegia/hemiparesis
- At least six months post-stroke
- Upper Extremity Fugl-Meyer Assessment score "moderate" or "moderate-mild" (29-53 inclusive out of 66) at the screening visit
- Medically and neurologically stable, as determined by medical history and documented physical examination
- For women of childbearing potential, a negative over-the-counter pregnancy test at study entry and willingness to practice adequate contraception during the study
- Ability to attend sessions three times per week
- Adequate social support to participate in all intervention and baseline, follow-up assessment sessions throughout eight months.
- Ability to read, comprehend and speak English
Exclusion Criteria:
- Hemorrhagic stroke
- History of multiple strokes
- Active implanted stimulator (e.g., pacemaker, vagus nerve stimulator, cochlear implant, etc.) or baclofen pump
- Aphasia or any other deficit in communication that interferes with reasonable study participation
- Moderate to severe cognitive impairment
- Presence of neglect (inability to perceive or awareness of, or loss of attention to the weaker half of the body)
- Severe spasticity in the upper limb
- Taking baclofen more than 30 mg/day
- Change in baclofen dose within four weeks before enrollment
- Receiving benzodiazepines, dantrolene, tizanidine, anticoagulant, or antiepileptic medication
- Botulinum toxin injection to the upper limb muscles within six months before enrollment
- Severe joint contractures in the affected hand and arm
- History of spontaneous seizure that had occurred one month or longer after the stroke
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Activity Based Rehabilitation
Activity Based Rehabilitation is comprised of intensive, progressive, functional task practice.
The protocol consists of repetitive activities of gross upper limb movement, isolated finger movements, bimanual task performance, simple and complex pinch, and grip performance.
Several activities with various difficulty levels are designated for each category, and the participant will perform 1-2 activities within each category in each rehabilitation session.
Rehabilitation sessions will be three times per week, 90 minutes per session for six weeks (total of 18 sessions).
|
Exercise therapy targeting paralyzed hand and arm
|
Experimental: Non-invasive Electrical Spinal Cord Stimulation + Activity Based Rehabilitation
Non-invasive electrical spinal cord stimulation will be performed using surface electrodes placed over the skin of the neck.
Biphasic rectangular pulses of 1 millisecond per phase duration will be delivered with a 10 kiloHertz overlapping frequency and between 20-120 Hertzz burst frequency.
Non-invasive electrical spinal cord stimulation will be paired with Activity Based Rehabilitation sessions.
Stimulation plus rehabilitation sessions will be three times per week, 90 minutes per session for six weeks (total of 18 sessions).
|
Exercise therapy targeting paralyzed hand and arm
Electrical stimulation of the spinal cord using surface electrodes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline - Fugl-Meyer assessment of the upper limb
Time Frame: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
The clinician-administered a stroke-specific, performance-based impairment scale.
It assesses movement function, sensation, joint range of motion, and pain.
The score ranges from 0 to 66. Higher scores indicate better outcomes.
|
"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Change from baseline - Pinch and grip force
Time Frame: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Measurement of hand strengths using a dynamometry.
|
"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Change from baseline - Modified Ashworth Scale
Time Frame: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Clinician-administered test for resistance of a joint to passive movement.
This scale grades muscle tone/spasticity.
The score ranges from 0 to 4. Higher scores indicate worse outcomes.
|
"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Change from baseline - Wolf Motor Function Test
Time Frame: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Quantifies upper limb motor ability through timed and functional tasks.
The score range is 0-75; higher scores denote better function.
|
"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline - Action Research Arm Test
Time Frame: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Clinician-administered observational measure to assess upper extremity performance, such as coordination, dexterity, and functioning, in stroke recovery.
|
"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Change from baseline - Box and Blocks Test
Time Frame: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Participants move, one by one, the maximum number of blocks from one compartment of a box to another of equal size within 60 seconds.
Measures gross manual dexterity.
|
"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Change from baseline - Revised Nottingham Sensory Assessment
Time Frame: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
A standardized scale for assessing sensory impairment in stroke patients.
Tactile sensation, proprioception, stereognosis, and two-point discrimination are evaluated.
|
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
Change from baseline - Stroke Impact Scale
Time Frame: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
A self-report questionnaire that evaluates disability and health-related quality of life after stroke.
The questionnaire consists of 8 domains: strength, memory and thinking, emotion, communication, activities of daily living, mobility, hand function, and participation/role function.
The score ranges from 0 to 100.
Higher scores indicate better outcomes.
|
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
Change from baseline - Short Form-36
Time Frame: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
A self-report health survey questionnaire.
The score range from 0 to 100.
The higher the score, the better the outcome.
|
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
Change from baseline - Patients Global Impression of Change
Time Frame: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
A self-report measure that reflects the participant's belief about the efficacy of treatment: the participant chooses the level of improvement and their functional status between much worse, worse, no change, improved and much improved, compared to the baseline.
|
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
Change from baseline - H-reflex test
Time Frame: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
Electrophysiologic evaluation of the reflex response triggered on the motor nerves when sensory fibers in the peripheral nerve are stimulated.
|
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
Change from baseline - Somatosensory evoked potentials test
Time Frame: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
Electrophysiologic evaluation of sensory pathways between the brain and the limb.
|
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
Change from baseline - Spinally evoked motor potentials test
Time Frame: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
Electrophysiologic evaluation of motor pathways between the central nervous system and the muscles.
|
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Chet Moritz, PhD, University of Washington
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00015990
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke, Ischemic
-
Nordsjaellands HospitalRigshospitalet, Denmark; Metropolitan University CollegeCompletedTransient Ischemic Attack | Stroke, Ischemic | Stroke HemorrhagicDenmark
-
University of CalgaryThe George Institute for Global Health, AustraliaNot yet recruitingAcute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke AcuteCanada, Australia
-
Second Affiliated Hospital, School of Medicine,...Shanghai Zhongshan Hospital; First Affiliated Hospital of Wenzhou Medical University and other collaboratorsRecruitingAcute Ischemic Stroke and Transient Ischemic AttacksChina
-
Medtronic Cardiac Rhythm and Heart FailureMedtronic Bakken Research CenterCompletedCryptogenic Symptomatic Transient Ischemic Attack | Cryptogenic Ischemic StrokeNetherlands, United States, France, Belgium, Germany, Sweden, Italy, Austria, Canada, Denmark, Finland, Greece, Slovakia, Spain
-
University Hospital, BrestCompletedStroke, Ischemic | Stroke HemorrhagicFrance
-
Umbria Bioengineering TechnologiesRecruitingStroke, Ischemic | Stroke HemorrhagicItaly
-
Sheffield Teaching Hospitals NHS Foundation TrustUnknownFatigue | Stroke, Ischemic | Stroke HemorrhagicUnited Kingdom
-
BayerRecruitingAcute Non-cardioembolic Ischemic Stroke | Prevention of Ischemic Stroke | High-risk Transient Ischemic AttackUnited States, Switzerland, Belgium, Sweden, Canada, Australia, Taiwan, Spain, Korea, Republic of, Latvia, Israel, Malaysia, Greece, Japan, Turkey, Netherlands, Romania, China, United Kingdom, Portugal, Italy, Brazil, France, Slovakia, ... and more
-
University of AlbertaCompletedTransient Ischemic Attack | Minor Ischemic StrokeCanada
-
Stephanie HarrisonActive, not recruitingTransient Ischemic Attack | Stroke, IschemicUnited Kingdom
Clinical Trials on Activity Based Rehabilitation
-
Thomas Jefferson UniversityNational Institute on Disability, Independent Living, and Rehabilitation...Active, not recruitingUnderstanding Experiences of People With Spinal Cord Injury Undergoing Activity-based RehabilitationSpinal Cord InjuriesUnited States
-
University Health Network, TorontoNot yet recruitingFall | Spinal Cord Injuries | Muscle ParesesCanada
-
Aveiro UniversityFundação para a Ciência e a Tecnologia; Centro Hospitalar do Baixo Vouga; Administração... and other collaboratorsCompleted
-
University of Erlangen-NürnbergBad Reichenhall Clinic, Center for Rehabilitation, Pulmonology and Orthopedics and other collaboratorsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany
-
La Trobe UniversityMonash University; The Alfred; Austin HealthCompletedChronic Obstructive Pulmonary DiseaseAustralia
-
Istanbul Medipol University HospitalRecruitingLung Diseases | Bronchiectasis | Lung Diseases, Interstitial | Pulmonary RehabilitationTurkey
-
Istanbul Medipol University HospitalCompletedEmphysema | Bronchoscopic Lung Volume Reduction | Hospital-based Pulmonary Rehabilitation | Home-based Pulmonary RehabilitationTurkey
-
Istituti Clinici Scientifici Maugeri SpANot yet recruitingCognitive Impairment | Dementia | Vascular Dementia | Dementia, Mixed | Comorbidities and Coexisting Conditions
-
National Cheng-Kung University HospitalCompletedTelerehabilitation | Pulmonary Rehabilitation | Compliance, Patient | COPD | Cardiopulmonary Exercise TestTaiwan
-
Copenhagen University Hospital, HvidovreUniversity of Copenhagen; Sygekassernes Helsefond; The Danish Rheumatism Association and other collaboratorsRecruitingOsteoarthritis, KneeDenmark